Table 4.
Sample | Type† | CDC | Panbio | XCyton | InBios | Panbio Adjusted |
---|---|---|---|---|---|---|
1 | High serum | > 12,800 | 3,200 | 6,400 | > 12,800 | N/A |
2 | High serum | > 12,800 | 200 | 1,600 | > 12,800 | N/A |
3 | High serum | > 12,800 | 3,200 | > 12,800 | > 12,800 | N/A |
4 | High CSF | > 1,280 | 40 | 20 | 320 | 20 |
5 | Low CSF | 80 | 10 | < 10 | < 10 | 10 |
Endpoints are given as the reciprocal of the highest dilution at which Japanese encephalitis virus (JEV) IgM was detected by the assay from an initial serum dilution of 1:100 diluted 4-fold to 1:12800 and initial cerebrospinal fluid (CSF) dilution of 1:10 diluted 2-fold to 1:1280. Endpoints of > 12,800 (sera) or > 1,280 (CSF) indicate that JEV IgM was detected by the assay to the final dilution of the analysis.
Based on initial Centers for Disease Control and Prevention (CDC) Japanese encephalitis virus (JEV) IgM antibody capture enzyme-linked immunosorbent assay (MAC ELISA) results at 1:400 (sera) and 1:10 (CSF) screening dilutions. High serum or CSF, P/N > 20; low CSF, P/N < 10.